𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives

✍ Scribed by Rothschild, Rachel ;Quitkin, H. Matthew ;Quitkin, Frederic M. ;Stewart, Jonathan W. ;Ocepek-Welikson, Katja ;McGrath, Patrick J. ;Tricamo, Elaine

Publisher
Wiley (John Wiley & Sons)
Year
1994
Tongue
English
Weight
606 KB
Volume
15
Category
Article
ISSN
0276-3478

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imipramine in the treatment of bulimia:
Imipramine in the treatment of bulimia: A double-blind controlled study
✍ Agras, W. Stewart ;Dorian, Barbara ;Kirkley, Betty G. ;Arnow, Bruce ;Bachman, Jo 📂 Article 📅 1987 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 506 KB

There were 22 bulimic women who participated in a double-blind placebo-controlled study of the effects' of imipramine hydrochloride in the treatment of bulimia over a 16 week period. Participants receiving the active drug demonstrated a significantly greater reduction in purging (frequency of self-i

A double-blind comparison of the efficac
A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia
✍ Cornelius L. E. Katona; Brian N. Hunter; Julia Bray 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 2 views

Objectives. To compare the ecacy of paroxetine and imipramine prospectively in patients with coexisting depression and dementia. Methods. An 8-week, double-blind, parallel group trial comparing paroxetine 20±40 mg/day with imipramine 50±100 mg/day in 198 patients aged 60 years or over with a Montgo

Comparison of desipramine and citalopram
Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebo-controlled study
✍ David Devos; Kathy Dujardin; Isabelle Poirot; Caroline Moreau; Olivier Cottencin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract Depression is one of the most common psychiatric disturbances in Parkinson's disease (PD). Recent reviews have highlighted the lack of controlled trials and the ensuing difficulty in formulating recommendations for antidepressant use in PD. We sought to establish whether antidepressants

Hypericum treatment of mild–moderate dep
Hypericum treatment of mild–moderate depression in a placebo–controlled study. A prospective, double–blind, randomized, placebo–controlled, multicentre study
✍ E. Schrader; B. Meier; A. Brattström 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

A prospective, randomized, multicentre, double-blind placebo controlled study is described which compares the ecacy and tolerability of hypericum administered as a concentrated ethanolic extract of St John's wort (ZE117) to patients with mild±moderate depression (ICD-10; F 32 . 0 mild; F 32 . 1 mode

Double-blind comparison of citalopram an
Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia
✍ Joseph Mendels; Ari Kiev; Louis F. Fabre 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## This multicenter study compared the efficacy and safety of citalopram and placebo in a population of moderately to severely depressed patients with melancholia. This randomized, double-blind, parallel-group study compared citalopram (flexible dose; 20-80 mg/day) with placebo in 180 psychiatric ou

A double-blind placebo-controlled trial
A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia
✍ Olivier Vitton; Michael Gendreau; Judy Gendreau; Jay Kranzler; Srinivas G. Rao 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

Fibromyalgia syndrome is a systemic disorder of widespread pain which is thought to result from abnormal pain processing within the central nervous system. There are no currently approved treatments for this indication. Antidepressants appear, however, to be effective, especially those with an actio